Paul Lohan

1.3k total citations
18 papers, 968 citations indexed

About

Paul Lohan is a scholar working on Genetics, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Lohan has authored 18 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Surgery and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Lohan's work include Mesenchymal stem cell research (14 papers), Tissue Engineering and Regenerative Medicine (8 papers) and Corneal Surgery and Treatments (7 papers). Paul Lohan is often cited by papers focused on Mesenchymal stem cell research (14 papers), Tissue Engineering and Regenerative Medicine (8 papers) and Corneal Surgery and Treatments (7 papers). Paul Lohan collaborates with scholars based in Ireland, Australia and Mexico. Paul Lohan's co-authors include Thomas Ritter, Aideen E. Ryan, Matthew D. Griffin, Oliver Treacy, Senthilkumar Alagesan, Kevin Lynch, Mary Murphy, Lisa O’Flynn, Nick Murphy and Cynthia M. Coleman and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Paul Lohan

18 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Lohan Ireland 16 539 314 266 187 167 18 968
Oliver Treacy Ireland 16 671 1.2× 380 1.2× 334 1.3× 143 0.8× 188 1.1× 26 1.1k
Lisa O’Flynn Ireland 15 783 1.5× 388 1.2× 344 1.3× 69 0.4× 213 1.3× 21 1.2k
Soraya Carrancio Spain 15 380 0.7× 175 0.6× 298 1.1× 52 0.3× 160 1.0× 33 1.0k
Elsa Vertua Italy 16 980 1.8× 776 2.5× 399 1.5× 266 1.4× 193 1.2× 24 1.5k
Sabine François France 16 1.2k 2.2× 540 1.7× 454 1.7× 277 1.5× 208 1.2× 31 1.8k
Peilong Lai China 15 452 0.8× 172 0.5× 716 2.7× 92 0.5× 265 1.6× 52 1.4k
Fausto Zorzi Italy 15 662 1.2× 508 1.6× 471 1.8× 108 0.6× 70 0.4× 48 1.4k
Sandra Cid Spain 10 567 1.1× 294 0.9× 517 1.9× 49 0.3× 117 0.7× 13 1.3k
Patrizia Bonassi Signoroni Italy 14 588 1.1× 536 1.7× 275 1.0× 166 0.9× 119 0.7× 21 1.1k
Melissa van Pel Netherlands 17 322 0.6× 196 0.6× 311 1.2× 37 0.2× 257 1.5× 47 1.0k

Countries citing papers authored by Paul Lohan

Since Specialization
Citations

This map shows the geographic impact of Paul Lohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lohan more than expected).

Fields of papers citing papers by Paul Lohan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Lohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lohan. The network helps show where Paul Lohan may publish in the future.

Co-authorship network of co-authors of Paul Lohan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Lohan. A scholar is included among the top collaborators of Paul Lohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Lohan. Paul Lohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Treacy, Oliver, Kevin Lynch, Nick Murphy, et al.. (2021). Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice. Stem Cell Research & Therapy. 12(1). 227–227. 8 indexed citations
2.
Lynch, Kevin, Oliver Treacy, Xizhe Chen, et al.. (2020). TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo. Molecular Therapy. 28(9). 2023–2043. 52 indexed citations
3.
Armitage, W. John, Matthew D. Griffin, Jesper Hjortdal, et al.. (2019). High-risk Corneal Transplantation: Recent Developments and Future Possibilities. Transplantation. 103(12). 2468–2478. 99 indexed citations
4.
Murphy, Nick, Oliver Treacy, Kevin Lynch, et al.. (2019). TNF‐α/IL‐1β—licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell‐mediated induction of Foxp3 + regulatory T cells in the lung. The FASEB Journal. 33(8). 9404–9421. 41 indexed citations
5.
O’Malley, Grace, Oliver Treacy, Kevin Lynch, et al.. (2018). Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer. Cancer Immunology Research. 6(11). 1426–1441. 68 indexed citations
6.
Lohan, Paul, Nick Murphy, Oliver Treacy, et al.. (2018). Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation. Frontiers in Immunology. 9. 2666–2666. 44 indexed citations
7.
Lohan, Paul, Oliver Treacy, Aideen E. Ryan, et al.. (2018). Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat. Stem Cells. 36(8). 1210–1215. 22 indexed citations
8.
Lohan, Paul, Oliver Treacy, Matthew D. Griffin, Thomas Ritter, & Aideen E. Ryan. (2017). Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?. Frontiers in Immunology. 8. 1626–1626. 117 indexed citations
9.
Lynch, Kevin, Oliver Treacy, Jared Q. Gerlach, et al.. (2017). Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment. Frontiers in Immunology. 8. 1427–1427. 15 indexed citations
10.
Murphy, Nick, Kevin Lynch, Paul Lohan, Oliver Treacy, & Thomas Ritter. (2016). Mesenchymal stem cell therapy to promote corneal allograft survival. Current Opinion in Organ Transplantation. 21(6). 559–567. 21 indexed citations
11.
Ritter, Thomas, Oliver Treacy, Grace O’Malley, et al.. (2016). Extracellular Vesicles Derived From Mesenchymal Stem Cells for Treatment of Ocular Surface Injuries. The FASEB Journal. 30(S1). 1 indexed citations
12.
Lohan, Paul, Oliver Treacy, Kevin Lynch, et al.. (2015). Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response. Osteoarthritis and Cartilage. 24(3). 521–533. 26 indexed citations
13.
Lohan, Paul, Cynthia M. Coleman, Mary Murphy, et al.. (2014). Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?. Stem Cell Research & Therapy. 5(4). 99–99. 60 indexed citations
14.
Treacy, Oliver, Lisa O’Flynn, Aideen E. Ryan, et al.. (2014). Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation. American Journal of Transplantation. 14(9). 2023–2036. 40 indexed citations
15.
Ryan, Aideen E., et al.. (2014). Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis. Oncogene. 34(12). 1563–1574. 48 indexed citations
16.
Ryan, Aideen E., Paul Lohan, Lisa O’Flynn, et al.. (2013). Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation. Molecular Therapy. 22(3). 655–667. 82 indexed citations
17.
Treacy, Oliver, Aideen E. Ryan, Lisa O’Flynn, et al.. (2012). Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation. PLoS ONE. 7(8). e42662–e42662. 33 indexed citations
18.
Griffin, Matthew D., Aideen E. Ryan, Senthilkumar Alagesan, et al.. (2012). Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. Immunology and Cell Biology. 91(1). 40–51. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026